Tharimmune, Inc. (THAR)
NASDAQ: THAR · IEX Real-Time Price · USD
0.430
-0.003 (-0.65%)
At close: Mar 28, 2024, 4:00 PM
0.431
+0.001 (0.19%)
After-hours: Mar 28, 2024, 5:38 PM EDT

Tharimmune Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Selling, General & Admin
5.94.61.370.670.63
Research & Development
3.562.281.840.850.37
Other Operating Expenses
0000.290.43
Operating Expenses
9.466.883.211.811.42
Operating Income
-9.46-6.88-3.21-1.81-1.42
Interest Expense / Income
0.021.590.830.250.08
Other Expense / Income
-0.15--1.830.360.03
Pretax Income
-9.32-8.47-2.21-2.42-1.53
Net Income
-9.32-8.47-2.21-2.42-1.53
Shares Outstanding (Basic)
10000
Shares Outstanding (Diluted)
10000
Shares Change
188.38%78.02%0.16%69.08%-
EPS (Basic)
-7.14-18.72-8.75-9.50-10.25
EPS (Diluted)
-7.14-18.72-8.75-9.50-10.25
Free Cash Flow
-7.3-6.56-1.09-1.08-0.71
Free Cash Flow Per Share
-5.59-14.49-4.27-4.25-4.70
EBITDA
-9.3-6.88-1.38-2.17-1.45
EBIT
-9.3-6.88-1.38-2.17-1.45
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).